Evidence map›Paper›PMID 30158706›Full record

ArticleNature2018

Structures of filaments from Pick's disease reveal a novel tau protein fold.

Benjamin Falcon, Wenjuan Zhang, Alexey G Murzin, Garib Murshudov, Holly J Garringer, Ruben Vidal, R Anthony Crowther, Bernardino Ghetti, Sjors H W Scheres, Michel Goedert

Registry-linked trialOpen access · greenAbstract readComparative Study
In one paragraph

Article in Nature, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05269394 (A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease), which is not on this map. Cited by 483 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
483citing papers in PubMed, 1 pooled it
56.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05269394 phase2 / phase3active not recruitingnot on this mapstarted 2021, after this paper: background citation

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease

TypeinterventionalSponsorWashington University School of MedicineRan2021 to 2028Enrolled197ConditionsAlzheimers Disease, Dementia, Alzheimers Disease, FamilialArmsE2814, Lecanemab, Matching Placebo (E2814)
3 · Its place in the literature

Who cites it

483 citing papers in PubMed, 1 synthesis or guideline pooled it, 870 citations in OpenAlex.

  1. Pooled it
  2. Dynamic [Molecular neurodegeneration · 2026
    Article
  3. A water-pinning hotspot drives templated tau aggregation.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Riboregulation: a non-canonical tau function.Molecular neurodegeneration · 2026
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

423 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Benjamin FalconMRC Laboratory of Molecular Biology, Cambridge, UK.
Wenjuan ZhangMRC Laboratory of Molecular Biology, Cambridge, UK.
Alexey G MurzinMRC Laboratory of Molecular Biology, Cambridge, UK.
Garib MurshudovMRC Laboratory of Molecular Biology, Cambridge, UK.
Holly J GarringerDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Ruben VidalDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
R Anthony CrowtherMRC Laboratory of Molecular Biology, Cambridge, UK.
Bernardino GhettiDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Sjors H W ScheresMRC Laboratory of Molecular Biology, Cambridge, UK. scheres@mrc-lmb.cam.ac.uk.
Michel GoedertMRC Laboratory of Molecular Biology, Cambridge, UK. mg@mrc-lmb.cam.ac.uk.
MRC Laboratory of Molecular Biology · GBIndiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Research Education ComponentP30AG010133 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI GHETTI, BERNARDINO FRANCESCO · 1991 to 2020
$37.3M
PHARMACOLOGY AND TOXICOLOGY OF ANTITUMOR AGENTSK04CA001012 · NCI · YALE UNIVERSITY · PI LAZO, JOHN S · 1985 to 1989
–
Medical Research Council MC_U105184291Medical Research Council MC_U105192716Medical Research Council MC_UP_A025_1012Medical Research Council MC_UP_A025_1013NIA NIH HHS P30 AG010133
6 · The paper itself

Abstract

The ordered assembly of tau protein into abnormal filamentous inclusions underlies many human neurodegenerative diseases

Indexed as

Protein FoldingAlzheimer DiseaseAmino Acid SequenceBrainCryoelectron MicroscopyHumansModels, MolecularPhosphorylationPick Disease of the BrainProtein IsoformsTauopathiestau ProteinsProtein Isoformstau Proteins

Identifiers

PMID30158706
PMCPMC6204212
OpenAlexW2796637563

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.